- All sections
- C - Chemistry; metallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
- C12Q 1/6809 - Methods for determination or identification of nucleic acids involving differential detection
Patent holdings for IPC class C12Q 1/6809
Total number of patents in this class: 2217
10-year publication summary
134
|
136
|
151
|
99
|
211
|
253
|
263
|
238
|
174
|
35
|
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Prognosys Biosciences, Inc. | 85 |
54 |
The Board of Trustees of the Leland Stanford Junior University | 5729 |
35 |
The Chinese University of Hong Kong | 567 |
35 |
Verinata Health, Inc. | 99 |
31 |
Sequenom, Inc. | 300 |
27 |
The Regents of the University of California | 18192 |
26 |
Dana-Farber Cancer Institute, Inc. | 2351 |
26 |
University Health Network | 916 |
26 |
President and Fellows of Harvard College | 5537 |
25 |
Genomic Health, Inc. | 196 |
25 |
Natera, Inc. | 239 |
24 |
Massachusetts Institute of Technology | 9560 |
22 |
Illumina, Inc. | 2278 |
22 |
The Broad Institute, Inc. | 1359 |
21 |
The Chinese University of Hong Kong | 146 |
18 |
Genentech, Inc. | 3576 |
16 |
Centre National de La Recherche Scientifique | 9183 |
15 |
Toray Industries, Inc. | 6442 |
15 |
Becton, Dickinson and Company | 6106 |
14 |
The General Hospital Corporation | 4364 |
14 |
Other owners | 1726 |